ClinicalTrials.Veeva

Menu

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function. (DKD-EXT)

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Focus Type 2 Diabetes Related Chronic Kidney Disease

Treatments

Behavioral: Exercise

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02112071
K23DK082638-04 (U.S. NIH Grant/Contract)
22275 (Other Identifier)
0905M66282

Details and patient eligibility

About

The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).

Enrollment

122 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • An individual must be >18 years of age

Have diagnosed type 2 diabetic mellitus by one of the following criteria:

o Treated with diet, diet plus oral hypoglycemic agents (for at least one year), or insulin preceded by treatment with oral agents (for at least one year).

If treated with insulin, the onset of diabetes must have occurred after age of 40 and the body mass index must be >25kg/m2 at the time of diagnosis.

Diagnosed kidney attributed to diabetes by one of the following criteria:3

  • Macroalbuminuria (ACR >300mg/g, or)

  • Microalbuminuria (ACR between 30-300 mg/g) or in the presence of diabetic retinopathy (although is recognized that about 1/3 of type 2 diabetics do not have retinopathy by fundoscopic exam).

  • An elevated ACR should have been confirmed in the absence of urinary tract infections with 2 additional first-void specimens collected over 3-6 months.

  • At least 2 of 3 samples should fall within the range of micro or macroalbuminuria.

    • An estimated Glomerular filtration rate (GFR) of between 90 ml/min and 30 ml/min measured by (GFR (mL/min/1.73 m2) = 186 x (Scr)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if African-American) (conventional units).
    • Individuals must be able to provide informed consent
    • Perform walking exercise testing on a treadmill
    • Be able to participate in a 12-week supervised exercise program.

Exclusion criteria

  • • Patients are currently exercising

    • Requiring dialysis
    • Have an Hematocrit <30%
    • Uncontrolled hypertension (>200/100mmHg)
    • Peripheral vascular disease.
    • An inability to understand English or give consent. Other exclusion criteria are: any contraindications to exercise testing or training as indicated by the American College of Sports Medicine guidelines such as: Unstable coronary heart disease and symptomatic heart failure, exercise capacity limited by health problems such as angina, severe arthritis, or extreme dyspnea on exertion, progressive neuromuscular disease, pulmonary disease., or having undergone a coronary revascularization within the past 6 months prior to enrollment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

122 participants in 2 patient groups

Exercise
Experimental group
Description:
blended supervised-hombased exercise training 3-4 times/week for 12 weeks
Treatment:
Behavioral: Exercise
control
No Intervention group
Description:
control group asked to continue usual activities

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems